Porcine embryonic stem cells: a possible source for cell replacement therapy.

Area of Science:

• Reproductive Biology
• Developmental Biology
• Stem Cell Science

Background:

• Porcine embryonic stem cell lines (pESCs) are vital for advancing immunocompatible transgenic pig production.
• Current in-vitro pESC derivation faces significant challenges, potentially due to species-specific developmental differences.
• Existing research highlights distinct expression patterns of pluripotency markers (Oct4, Nanog, Sox2) in porcine blastocysts compared to mouse and human models.

Purpose of the Study:

• To review the molecular profile of porcine pre-implantation development.
• To provide a historical overview of pESC development efforts.
• To identify knowledge gaps in porcine pluripotency and early development.

Main Methods:

• Literature review of porcine pre-implantation development.
• Analysis of gene expression patterns in porcine blastocysts.
• Historical compilation of pESC derivation attempts.

Main Results:

• Porcine pre-implantation development exhibits unique characteristics, including later epiblast formation (days 7-8) and extended maintenance before differentiation.
• Differences in Oct4, Nanog, and Sox2 expression suggest alternative mechanisms maintain pluripotency in early porcine blastocysts.
• The review consolidates current knowledge and historical attempts at pESC development.

Conclusions:

• Understanding the molecular basis of porcine pluripotency and pre-implantation development is essential.
• Further research into species-specific factors is needed to improve pESC derivation efficiency.
• Enhanced knowledge will facilitate the production of reliable pESC lines for biotechnological applications.